ATE356118T1 - Moexipril-magnesium enthaltende arzneimittel - Google Patents

Moexipril-magnesium enthaltende arzneimittel

Info

Publication number
ATE356118T1
ATE356118T1 AT01302450T AT01302450T ATE356118T1 AT E356118 T1 ATE356118 T1 AT E356118T1 AT 01302450 T AT01302450 T AT 01302450T AT 01302450 T AT01302450 T AT 01302450T AT E356118 T1 ATE356118 T1 AT E356118T1
Authority
AT
Austria
Prior art keywords
moexipril
magnesium
products containing
medicinal products
acid addition
Prior art date
Application number
AT01302450T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4165724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE356118(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of ATE356118T1 publication Critical patent/ATE356118T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01302450T 2000-04-05 2001-03-16 Moexipril-magnesium enthaltende arzneimittel ATE356118T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002303481A CA2303481A1 (en) 2000-04-05 2000-04-05 Pharmaceutical compositions comprising moexipril magnesium

Publications (1)

Publication Number Publication Date
ATE356118T1 true ATE356118T1 (de) 2007-03-15

Family

ID=4165724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01302450T ATE356118T1 (de) 2000-04-05 2001-03-16 Moexipril-magnesium enthaltende arzneimittel

Country Status (5)

Country Link
US (1) US6767556B2 (de)
EP (1) EP1142878B1 (de)
AT (1) ATE356118T1 (de)
CA (1) CA2303481A1 (de)
DE (1) DE60127019T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157165A1 (en) * 2002-02-01 2003-08-21 Sherman Bernard Charles Stable saccharide-free tablets comprising a salt of quinapril or moexipril
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
CN101812018B (zh) * 2010-04-20 2011-10-12 合肥合源药业有限公司 一种稳定的莫昔普利金属盐及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
DE19913528A1 (de) * 1998-12-21 2000-06-29 Sanol Arznei Schwarz Gmbh Neue Verwendung von Moexipril

Also Published As

Publication number Publication date
CA2303481A1 (en) 2001-10-05
DE60127019D1 (de) 2007-04-19
US20020037858A1 (en) 2002-03-28
EP1142878A2 (de) 2001-10-10
DE60127019T2 (de) 2007-11-15
EP1142878B1 (de) 2007-03-07
US6767556B2 (en) 2004-07-27
EP1142878A3 (de) 2003-09-17

Similar Documents

Publication Publication Date Title
DK0623607T3 (da) Benzofuranyl- og -thiophenyl-alkancarboxylsyrederivater
ATE478841T1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
WO2005085234A3 (en) Bycyclic anthranilamide derivatives useful as insecticides
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
NO20054787D0 (no) Indenderivater som farmasotiske midler
WO2001017973A3 (de) Neue herbizide
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
EP1314712A4 (de) Substituierte benzoesäurederivate als nf-kappa-b-inhibitoren
EA200500368A1 (ru) Фунгицидная композиция, содержащая масло чайного дерева
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
WO2007058568A3 (fr) Sels et melanges d'acide 9-oxoacridine-10-acetique et de 1-alkylamino-1-desoxypolyols, compositions pharmaceutiques les contenant, et methodes de traitement associees
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
BRPI0410602A (pt) formulações de barreira ao oxigênio
ATE356118T1 (de) Moexipril-magnesium enthaltende arzneimittel
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
ID30435A (id) Proses-proses untuk menyiapkan perantara-perantara pestisidal
AU2003256108A1 (en) Organic acid salt of amlodipine
GB0229453D0 (en) Improvements in or related to organic compounds
ATE354376T1 (de) Zusammensetzungen für die elektroporation
DE60029771D1 (de) Verfahren zur herstellung von 3,4-dihydrobutansäure und derivaten davon aus substituierten pentosezuckern
JPS545983A (en) Preparation of n'-(2-furanidyl)-5-fluorouracil
TH58437EX (th) ตัวเรือนนาฬิกา
TH78138B (th) สารผสมสำหรับการทำให้ขาว
TH58734EX (th) หอคอย (ของเล่น)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties